During the malaria-induced inflammatory processes, the treatment of macrophages with NRF2 inducers enhances the CD36 expression and CD36-mediated Plasmodium phagocytosis and thus the control of severe malaria through parasite clearance (Olagnier et al., 2011). Here, NFE2L2 is linked to malaria.